4D Molecular Therapeutics... (FDMT)
NASDAQ: FDMT
· Real-Time Price · USD
7.28
0.18 (2.54%)
At close: Aug 15, 2025, 3:59 PM
7.22
-0.76%
After-hours: Aug 15, 2025, 04:10 PM EDT
4D Molecular Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 33K | 23K | 37K | 17K | 20.22M | 20.45M | 20.72M | 21.99M | 2.28M | 2.21M | 3.13M | 1.97M | 2.84M | 17.26M | 18.04M | 16.97M | 23.02M | 12.08M |
Cost of Revenue | 5.38M | 5.11M | 6.71M | 9.16M | 8.85M | 8.65M | 8.47M | 5.62M | 5.11M | 4.51M | 3.88M | 4.38M | 19.34M | 33.73M | 45.72M | 56.44M | 52.15M | 52.65M |
Gross Profit | -3.64M | -3.38M | -4.96M | -7.44M | 11.37M | 11.8M | 12.25M | 16.36M | -2.82M | -2.3M | -752K | -2.41M | -16.5M | -16.48M | -27.68M | -39.47M | -29.13M | -40.57M |
Operating Income | -220.33M | -203.33M | -187.84M | -168.38M | -131.22M | -120.9M | -112.87M | -104.94M | -117.46M | -113.75M | -110.03M | -106.08M | -102.24M | -81.41M | -71.33M | -66.99M | -52.15M | -59.7M |
Interest Income | 24.2M | 26.89M | 27.05M | 24.96M | 21.55M | 16.51M | 12.21M | 9.17M | 6.09M | 3.92M | 2.57M | 1.24M | 875K | 542K | 449K | 453K | 22K | 29K |
Pretax Income | -196.14M | -176.44M | -160.87M | -143.48M | -109.89M | -104.56M | -100.84M | -95.93M | -111.37M | -109.84M | -107.49M | -105.2M | -101.75M | -81.25M | -71.32M | -66.78M | -52.38M | -59.94M |
Net Income | -196.14M | -176.44M | -160.87M | -143.48M | -109.89M | -104.56M | -99.41M | -94.4M | -108.24M | -106.03M | -104.95M | -102.77M | -100.91M | -81.09M | -71.32M | -66.78M | -52.38M | -59.94M |
Selling & General & Admin | 51.73M | 50.81M | 46.58M | 42.56M | 39.02M | 37.21M | 36.5M | 34.36M | 33.3M | 32.68M | 32.92M | 31.78M | 31.91M | 30.7M | 28.01M | 27.52M | 23.02M | 19.13M |
Research & Development | 170.22M | 154.13M | 141.3M | 124.24M | 110.82M | 102.55M | 97.09M | 92.56M | 86.44M | 83.27M | 80.24M | 76.27M | 73.17M | 67.97M | 61.36M | 56.44M | 52.15M | 52.65M |
Other Expenses | -3.38M | -3.38M | -3.39M | -21K | -179K | 2.34M | 3.77M | 3.79M | 3.96M | 1.44M | -34K | -44K | -66K | -66K | -121K | -243K | -251K | -269K |
Operating Expenses | 218.57M | 201.56M | 184.5M | 166.8M | 149.84M | 139.76M | 133.59M | 126.92M | 119.74M | 115.95M | 113.16M | 108.05M | 105.08M | 98.67M | 89.37M | 83.96M | 75.17M | 71.78M |
Interest Expense | n/a | n/a | n/a | 1.41M | 1.41M | 1.41M | 1.41M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 1.59M | 1.59M | n/a | -1.59M | -1.59M | -1.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 220.36M | 203.35M | 187.88M | 168.39M | 151.44M | 141.35M | 133.59M | 126.92M | 119.74M | 115.95M | 113.16M | 108.05M | 105.08M | 98.67M | 89.37M | 83.96M | 75.17M | 71.78M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | -1.42M | -1.53M | -3.13M | -3.81M | -2.54M | -2.43M | -834K | -154K | -7K | -11K | -15K | -29K |
Shares Outstanding (Basic) | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.28M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
Shares Outstanding (Diluted) | 55.93M | 55.74M | 53.94M | 55.55M | 55.28M | 49.27M | 39.13M | 42.26M | 38.34M | 32.72M | 32.49M | 32.39M | 32.32M | 32.23M | 27.02M | 27.02M | 26.74M | 26.69M |
EPS (Basic) | -3.53 | -3.18 | -2.98 | -2.91 | -2.36 | -2.5 | -2.67 | -2.68 | -3.18 | -3.26 | -3.24 | -3.33 | -3.41 | -2.84 | -2.64 | -2.48 | -2.02 | -2.76 |
EPS (Diluted) | -3.53 | -3.18 | -2.98 | -2.91 | -2.36 | -2.5 | -2.67 | -2.68 | -3.18 | -3.26 | -3.24 | -3.33 | -3.41 | -2.84 | -2.64 | -2.48 | -2.02 | -2.76 |
EBITDA | -221.79M | -203.17M | -187.84M | -161.94M | -125.09M | -114.97M | -107.12M | -99.31M | -112.35M | -109.24M | -106.15M | -101.7M | -98.36M | -77.99M | -68.31M | -65.49M | -50.66M | -58.22M |
EBIT | -215.53M | -203.33M | -187.84M | -168.38M | -131.22M | -120.9M | -112.87M | -104.94M | -117.46M | -113.75M | -110.03M | -106.08M | -102.24M | -81.41M | -71.33M | -66.99M | -52.15M | -59.7M |
Depreciation & Amortization | 424K | 160K | n/a | 6.43M | 6.13M | 5.93M | 5.75M | 5.62M | 5.11M | 4.51M | 3.88M | 4.38M | 3.88M | 3.42M | 3.02M | 1.5M | 1.49M | 1.48M |